Latest Industry Insights

Biopharmaceutical development is currently one of the fastest growing areas in the life sciences. With this comes an increasing need for analytical solutions able to cope with the challenges offered by biopharma samples. We spoke to Dr. Tom van de Goor from Agilent about how they are addressing these issues.

In this interview, Sudharshan Rangarajan discusses how laboratories can overcome some of the hurdles of incorporating automation into their workflow and highlights some of the solutions that Thermo Fisher Scientific offers in this space.

Multi-dimensional insights into the effects of drugs on protein structure and function can help de-risk the drug discovery process, building confidence in new drug candidates and their mechanism of action before moving on to the next more costly stage of development.

Technology Networks recently had the pleasure of speaking with ImVitro’s CEO and founder, Dr Alexandra Boussommier-Calleja, to learn more about IVF and how artificial intelligence (AI) could help to address some of the challenges associated with the technique.

Testing for the presence of the SARS-CoV-2 virus continues to be critical across the world, and will be in the future, particularly in light of new variants. The key to expanding and perfecting testing lies, arguably, in effective partnerships between organizations.

In this article, we outline how researchers at the University of Maastricht have used a novel spatial omics workflow to uncover proteomic profiles in tumor subpopulations of breast cancer.

Molecular Devices recently unveiled a brand new, first-of-its-kind Organoid Innovation Center. In this interview, Susan Murphy tells us more about the Center and discusses the advantages of automating organoid culturing and screening workflows.

To gain some insights into the role of NGS in global SARS-CoV-2 surveillance, we spoke to Michelle Fraser, general manager, NGS for PerkinElmer. Michelle also explains how labs working in this area can increase their throughput, decrease associated costs and simplify the analysis of NGS data collected.

Technology Networks recently interviewed Anthony V. Lemmo, to learn how rapid antigen tests work, how they compare to PCR tests and how they can be used to help slow the spread of SARS-CoV-2.

Public health groups and leaders around the world are adopting different approaches for viral tracking and monitoring to halt the spread of novel SARS-CoV-2 variants.